STECEF T 1.125
Indication
Ceftriaxone combined with Tazobactam, marketed as Stecef T 1.125, is an effective treatment for a wide range of bacterial infections. This combination harnesses the potent antibacterial properties of Ceftriaxone and the resistance- counteracting effects of Tazobactam, making it a powerful therapeutic option. Stecef T 1.125, containing Ceftriaxone 1gm + Tazobactam 125mg, is widely used in clinical settings for its enhanced efficacy.
Ceftriaxone is a broad-spectrum antibiotic that belongs to the third generation of cephalosporins. Its primary mechanism of action involves inhibiting the synthesis of the bacterial cell wall. Bacteria need a robust cell wall to maintain their structural integrity and protect themselves from the external environment. Ceftriaxone interferes with the formation of this vital protective covering by binding to specific penicillin-binding proteins (PBPs) inside the bacterial cell wall. This binding hampers the cross- linking of peptidoglycan chains, a critical process for cell wall strength and rigidity, ultimately leading to the lysis and death of the bacterial cells.
On the other hand, Tazobactam is a beta-lactamase inhibitor. Beta-lactamases are enzymes produced by certain bacteria that confer resistance to beta-lactam antibiotics like Ceftriaxone by breaking down their beta-lactam ring structure. Tazobactam works by inhibiting these enzymes, thereby preventing the degradation of Ceftriaxone. By protecting Ceftriaxone from enzymatic destruction, Tazobactam enhances its antibacterial activity and extends its spectrum of action against beta- lactamase-producing bacteria.
The synergy between Ceftriaxone and Tazobactam in Stecef T 1.125 broadens the scope of bacterial infections that can be effectively treated, including those caused by resistant strains. This combination is particularly valuable in treating severe infections such as sepsis, pneumonia, intra-abdominal infections, and urinary tract infections. Administered intravenously, Ceftriaxone and Tazobactam injection ensures rapid and efficient delivery of the medication to the site of infection.
For those looking to buy Stecef T 1.125, it is available for purchase online. Various suppliers and exporters offer Stecef T 1.125, ensuring accessibility for healthcare providers globally. When sourcing Stecef T 1.125, it is crucial to choose a reliable manufacturer to ensure the quality and efficacy of the product.
In summary, the combination of Ceftriaxone and Tazobactam in Stecef T 1.125 represents a robust therapeutic approach to combating bacterial infections. Ceftriaxone disrupts bacterial cell wall synthesis, while Tazobactam inhibits beta-lactamase enzymes, thereby enhancing Ceftriaxone's efficacy against resistant bacterial strains. This combination not only provides a broader spectrum of antibacterial activity but also helps in overcoming resistance mechanisms, making it a critical tool in the clinical management of bacterial infections.
Contraindication
Diarrhoea, Rashes, Nausea, Vomiting, Allergic dermatitis, Elevated serum glutamic pyruvic transaminase.
Storage
Cool & Dry Place
Dosage
As directed by a Medical Practitioner or Physician.
Inquire Now